Stefanie Remson
Nurse Practitioner · Henderson, NVNPI 1083981955
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,785 of the $6,515 with a category attached, or 88.8%. 20 manufacturers reported payments, led by Viiv Healthcare Company at 26.8% of the total. Among nurse practitioner clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 289 payments — averaging $22.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$2K
- Gilead$2K
- Merck$1K
- GSK$390
- Astellas Pharma US Inc$351
- Paratek Pharmaceuticals, Inc.$285
- plus $1K from 14 others
What the payments were for
- Consulting fees$3906%
- Food & beverage$5,78589%
- Education$3405%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 71 | $1,744 |
| Gilead | 80 | $1,520 |
| Merck | 46 | $1,017 |
| GSK | 1 | $390 |
| Astellas Pharma US Inc | 8 | $351 |
| Paratek Pharmaceuticals, Inc. | 24 | $285 |
| Ferring Pharmaceuticals Inc. | 14 | $282 |
| AbbVie | 11 | $239 |
| Aimmune Therapeutics, Inc. | 9 | $159 |
| Insmed, Inc. | 7 | $141 |
| Melinta Therapeutics, LLC | 4 | $101 |
| Napo Pharmaceuticals Inc | 3 | $58 |
| Shionogi Inc | 3 | $51 |
| Advanced Respiratory, Inc | 2 | $46 |
| Abbott | 1 | $27 |
| EMD Serono, Inc. | 1 | $25 |
| La Jolla Pharmaceutical Company | 1 | $25 |
| Redhill Biopharma Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Tactile Systems Technology Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,515 in reported general payments places this provider in the 90th percentile of 933 nurse practitioner providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 210 | $884,339 |
| TriumeqAbacavir/Dolutegravir/Lamivudi | 98 | $403,444 |
| OdefseyEmtricitab/Rilpiviri/Tenof Ala | 50 | $219,872 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 25 | $108,688 |
| GammakedImmune Globul G/Gly/Iga Avg 46 | 17 | $103,276 |
| IsentressRaltegravir Potassium | 36 | $75,310 |
| Daptomycin | 18 | $56,694 |
| TivicayDolutegravir Sodium | 15 | $37,234 |
| DescovyEmtricitabine/Tenofov Alafenam | 11 | $32,413 |
| Darunavir | 16 | $25,362 |
| MounjaroTirzepatide | 18 | $18,455 |
| ErtapenemErtapenem Sodium | 37 | $17,538 |
| Fosamprenavir Calcium | 13 | $10,785 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $4,306 |
| Rifampin | 48 | $3,337 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Genvoya, Descovy | $1,520 | $1,025,440246 claims |
| Viiv Healthcare CompanyTriumeq, Tivicay | $1,744 | $440,677113 claims |
| MerckIsentress | $1,017 | $75,31036 claims |
| GSKBreo Ellipta | $390 | $4,30611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 933 nurse practitioner providers in Nevada.
Other nurse practitioner in Henderson
- Charina TosteHenderson$393K
- Marites PilapilHenderson$11K
- Jackie ArmijoHenderson$11K
- Arianny Perrino LanzHenderson$9K
- Natalie HuxtableHenderson$7K
- Tiffany ShowHenderson$7K
- Bethany BairdHenderson$6K
- Melanie SpeedLas Vegas$80K
- Shelley MilesLas Vegas$34K
- Nasslynne LenzLas Vegas$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.